Published in Transplantation on June 27, 2009
Cytokines Evaluation in Early Calcineurin Inhibitors Withdrawn on Renal Transplant | NCT01239472
Urinary chemokines CXCL9 and CXCL10 are noninvasive markers of renal allograft rejection and BK viral infection. Am J Transplant (2011) 1.25
Subsets of human CD4(+) regulatory T cells express the peripheral homing receptor CXCR3. Eur J Immunol (2011) 0.96
Urinary C-X-C Motif Chemokine 10 Independently Improves the Noninvasive Diagnosis of Antibody-Mediated Kidney Allograft Rejection. J Am Soc Nephrol (2015) 0.96
Immune Monitoring as Prerequisite for Transplantation Tolerance Trials. Clin Exp Immunol (2017) 0.84
Effector mechanisms of rejection. Cold Spring Harb Perspect Med (2013) 0.79
CXCL10 and CXCL13 Expression were highly up-regulated in peripheral blood mononuclear cells in acute rejection and poor response to anti-rejection therapy. J Clin Immunol (2010) 0.79
Developing renal allograft surveillance strategies - urinary biomarkers of cellular rejection. Can J Kidney Health Dis (2015) 0.77
A Computational Gene Expression Score for Predicting Immune Injury in Renal Allografts. PLoS One (2015) 0.77
Role for urinary biomarkers in diagnosis of acute rejection in the transplanted kidney. World J Transplant (2015) 0.76
Combination of IL-1 receptor antagonist, IL-20 and CD40 ligand for the prediction of acute cellular renal allograft rejection. J Clin Immunol (2012) 0.76
Genomic and proteomic fingerprints of acute rejection in peripheral blood and urine. Transplant Rev (Orlando) (2014) 0.76
Biomarkers in kidney transplantation: From bench to bedside. World J Nephrol (2015) 0.75
Detecting Renal Allograft Inflammation Using Quantitative Urine Metabolomics and CXCL10. Transplant Direct (2016) 0.75
Advances in diagnostics for transplant rejection. Expert Rev Mol Diagn (2016) 0.75
Elevated Urinary T Helper 1 Chemokine Levels in Newly Diagnosed Hypertensive Obese Children. J Clin Res Pediatr Endocrinol (2015) 0.75
Urinary-cell mRNA profile and acute cellular rejection in kidney allografts. N Engl J Med (2013) 7.40
Liver transplantation for the treatment of hepatocellular carcinoma. Oncology (Williston Park) (2011) 2.14
Biologics in organ transplantation. Transpl Int (2012) 2.06
Outcomes at 3 years of a prospective pilot study of Campath-1H and sirolimus immunosuppression for renal transplantation. Transpl Int (2006) 1.68
Donation after cardiac death: the University of Wisconsin experience with liver transplantation. Ann Surg (2005) 1.67
Developmental exposure to noninherited maternal antigens induces CD4+ T regulatory cells: relevance to mechanism of heart allograft tolerance. J Immunol (2007) 1.64
Evaluation of clinical outcomes of prophylactic versus preemptive cytomegalovirus strategy in liver transplant recipients. Transpl Int (2013) 1.50
Selenium-binding protein-1 in smooth muscle cells is downregulated in a rhesus monkey model of chronic allograft nephropathy. Am J Transplant (2005) 1.45
Alemtuzumab induction and triple maintenance immunotherapy in kidney transplantation from donors after cardiac death. Transpl Int (2008) 1.44
Donation after cardiac death: the university of wisconsin experience with renal transplantation. Am J Transplant (2004) 1.26
Human CD4+CD25low adaptive T regulatory cells suppress delayed-type hypersensitivity during transplant tolerance. J Immunol (2007) 1.23
Risk factors and outcomes in post-liver transplantation bile duct stones and casts: A case-control study. Liver Transpl (2008) 1.23
Elevation of CXCR3-binding chemokines in urine indicates acute renal-allograft dysfunction. Am J Transplant (2004) 1.19
Overcoming Chronic Rejection-Can it B? Transplantation (2009) 1.17
Metastable tolerance to rhesus monkey renal transplants is correlated with allograft TGF-beta 1+CD4+ T regulatory cell infiltrates. J Immunol (2004) 1.17
Donation after cardiac death: the University of Wisconsin experience. Ann Transplant (2004) 1.14
Campath-1H use in pediatric renal transplantation. Am J Transplant (2005) 1.13
T-lymphocyte alloresponses of Campath-1H-treated kidney transplant patients. Transplantation (2006) 1.12
Macrophages driven to a novel state of activation have anti-inflammatory properties in mice. J Immunol (2008) 1.10
The evolving role of alemtuzumab (Campath-1H) for immunosuppressive therapy in organ transplantation. Transpl Int (2006) 1.08
CXCR3-mediated T-cell chemotaxis involves ZAP-70 and is regulated by signalling through the T-cell receptor. Immunology (2007) 1.04
Infected bilomas in liver transplant recipients, incidence, risk factors and implications for prevention. Am J Transplant (2004) 1.03
Underutilization of pancreas donors. Transplantation (2003) 0.98
Urine osteoprotegerin and monocyte chemoattractant protein-1 in lupus nephritis. J Rheumatol (2009) 0.98
Liver transplantation for HELLP syndrome. Liver Transpl (2005) 0.96
Nonhuman primate infections after organ transplantation. ILAR J (2008) 0.95
Simultaneous pancreas-kidney transplantation from donation after cardiac death: successful long-term outcomes. Ann Surg (2005) 0.93
Unique aspects of rejection and tolerance in liver transplantation. Semin Liver Dis (2009) 0.93
Monotherapy with the novel human anti-CD154 monoclonal antibody ABI793 in rhesus monkey renal transplantation model. Transplantation (2004) 0.93
Correlation between human leukocyte antigen antibody production and serum creatinine in patients receiving sirolimus monotherapy after Campath-1H induction. Transplantation (2004) 0.92
Hepatic enrichment and activation of myeloid dendritic cells during chronic hepatitis C virus infection. Hepatology (2012) 0.91
Tolerogenic therapies in transplantation. Front Immunol (2012) 0.88
Racial and socioeconomic disparities in pediatric and young adult liver transplant outcomes. Liver Transpl (2013) 0.88
Surveillance of acute rejection in baboon renal transplantation by elevation of interferon-gamma inducible protein-10 and monokine induced by interferon-gamma in urine. Transplantation (2004) 0.87
Interleukin-15 receptor blockade in non-human primate kidney transplantation. Transplantation (2010) 0.87
Transplant versus resection for the management of hepatocellular carcinoma meeting Milan Criteria in the MELD exception era at a single institution in a UNOS region with short wait times. J Surg Oncol (2013) 0.85
The effectiveness of locoregional therapies versus supportive care in maintaining survival within the Milan criteria in patients with hepatocellular carcinoma. J Vasc Interv Radiol (2010) 0.85
Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts. Transplantation (2003) 0.84
Determination of the functional status of alloreactive T cells by interferon-gamma kinetics. Transplantation (2006) 0.84
Challenging choices: liver transplantation for hepatocellular carcinoma. Ann Surg (2004) 0.83
Superior long-term results of simultaneous pancreas-kidney transplantation from pediatric donors. Am J Transplant (2004) 0.83
Piceatannol in combination with low doses of cyclosporine A prolongs kidney allograft survival in a stringent rat transplantation model. Transplantation (2002) 0.82
Infected bilomas in liver transplant recipients: clinical features, optimal management, and risk factors for mortality. Clin Infect Dis (2004) 0.82
The Association Between Hospital Finances and Complications After Complex Abdominal Surgery: Deficiencies in the Current Health Care Reimbursement System and Implications for the Future. Ann Surg (2015) 0.82
Urine proteomics in kidney transplantation. Transplant Rev (Orlando) (2013) 0.81
Rapamycin antagonizes cyclosporin A- and tacrolimus (FK506)-mediated augmentation of linker for activation of T cell expression in T cells. Int Immunol (2003) 0.81
Effect of immunosuppressants on T-cell subsets observed in vivo using carboxy-fluorescein diacetate succinimidyl ester labeling. Transplantation (2003) 0.80
Transient CD86 expression on hepatitis C virus-specific CD8+ T cells in acute infection is linked to sufficient IL-2 signaling. J Immunol (2010) 0.80
Antibody-mediated rejection of the kidney after simultaneous pancreas-kidney transplantation. J Am Soc Nephrol (2008) 0.80
Induction immunosuppression in liver transplantation: a review. Transpl Int (2013) 0.80
Primary vascularization of the graft determines the immunodominance of murine minor H antigens during organ transplantation. J Immunol (2011) 0.79
Immunotoxin-treated rhesus monkeys: a model for renal allograft chronic rejection. Transplantation (2003) 0.79
Alemtuzumab induction and recurrence of glomerular disease after kidney transplantation. Transplantation (2007) 0.79
The role of B cells in solid organ transplantation. Semin Immunol (2011) 0.79
Alemtuzumab induction and antibody-mediated kidney rejection after simultaneous pancreas-kidney transplantation. Transplantation (2009) 0.79
Donor-specific HLA-antibody-mediated humoral rejection in a liver transplant recipient fully reversed with plasmapheresis and immunoglobulin. Clin Transpl (2006) 0.78
Lymphodepletional strategies in transplantation. Cold Spring Harb Perspect Med (2013) 0.78
Long-term outcomes in simultaneous pancreas-kidney transplantation: lessons relearned. Clin Transpl (2003) 0.77
Systems biological analyses reveal the hepatitis C virus (HCV)-specific regulation of hematopoietic development. Hepatology (2015) 0.77
Prevention trumps treatment of antibody-mediated transplant rejection. J Clin Invest (2010) 0.77
Impact of Leukocyte Function-Associated Antigen-1 Blockade on Endogenous Allospecific T Cells to Multiple Minor Histocompatibility Antigen Mismatched Cardiac Allograft. Transplantation (2015) 0.76
Cross-talk between T and B Cells in the Germinal Center following Transplantation. Transplantation (2016) 0.75
Post-transplant lymphoproliferative disorder associated with immunosuppressive therapy for renal transplantation in rhesus macaques (Macaca mulatta). Exp Toxicol Pathol (2013) 0.75
Reply to Vanhove et al. Transpl Int (2013) 0.75
Cytokine kinetics profiling in pediatric renal transplant recipients. Pediatr Transplant (2010) 0.75
Incidental living donor nephrectomy: a unique expansion of the donor pool. Nephrol Dial Transplant (2005) 0.75
Liver transplantation for biliary atresia: 19-year, single-center experience. Exp Clin Transplant (2004) 0.75
The Volume-outcome Relationship in Deceased Donor Kidney Transplantation and Implications for Regionalization. Ann Surg (2017) 0.75
Annual literature review for clinical transplants 2005. Clin Transpl (2005) 0.75
Starting well: induction immunosuppression after organ transplantation. Transpl Int (2013) 0.75
Liver transplantation 2007: where do we go from here? Curr Opin Organ Transplant (2007) 0.75
Immune status assay (ISA): a noninvasive procedure for studying allograft rejection. Transpl Immunol (2004) 0.75